Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -1.48% | -35.87% | +12.02% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bioresorbable Hydrogel Platform Technology
99.0
%
| 50 | 98.0 % | 58 | 99.0 % | +14.69% |
Collaboration
1.0
%
| 1 | 2.0 % | 1 | 1.0 % | -44.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 51 | 100.0 % | 58 | 100.0 % | +13.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 17-09-24 |
Chief Tech/Sci/R&D Officer | - | 21-09-27 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-01-07 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-09-10 |
Peter Jarrett
CTO | Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Scott Corning
IRO | Public Communications Contact | - | 09-12-31 |
Tracy Smith
HRO | Human Resources Officer | - | 20-08-31 |
Peter K. Kaiser
PRN | Corporate Officer/Principal | - | Feb. 21 |
General Counsel | 64 | 20-08-24 | |
Corporate Officer/Principal | 62 | 19-07-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 23-07-09 |
Director/Board Member | 76 | 12-11-04 | |
Merilee Raines
BRD | Director/Board Member | 68 | 21-09-19 |
Director/Board Member | 55 | 07-12-31 | |
Leslie Williams
BRD | Director/Board Member | 64 | 19-03-19 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-09-10 |
Pravin Dugel
CEO | Chief Executive Officer | 60 | Feb. 20 |
Seung Suh Hong
BRD | Director/Board Member | 66 | 19-06-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 148,627,439 | 143,157,197 ( 96.32 %) | 0 | 96.32 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.02% | 785M | |
+27.33% | 659B | |
+27.68% | 557B | |
-4.56% | 359B | |
+16.45% | 322B | |
+9.49% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.70% | 149B |
- Stock Market
- Equities
- OCUL Stock
- Company Ocular Therapeutix, Inc.